abstract |
This invention provides a method for treating a subject with glaucoma comprising the steps of administrating a compound or composition which antagonizes, inhibits, inactives, reduces, suppresses, and/or limits the release, synthesis, or production from cells of TNF-α thereby treating the subject with glaucoma. |